Showing results (51-60 of 103) with videos related to
Sort By:
Pageof 11
Medcomm|May 19, 2025
Platelet-to-Neutrophil Ratio: A Novel Prognostic Indicator for Anti-PD-1-Based Therapy in Relapsed/Refractory Hodgkin Lymphoma and Solid TumorsYuting Pan, Xin Zhang, Chunmeng Wang, et al.Journal of Nanobiotechnology|April 4, 2024
Osteosarcoma-targeted Cu and Ce based oxide nanoplatform for NIR II fluorescence/magnetic resonance dual-mode imaging and ros cascade amplification along with immunotherapyMo Cheng, Qingjie Kong, Qing Tian, et al.Journal of Surgical Oncology|September 10, 2023
Prediction of nonsentinel lymph node metastasis in acral melanoma with positive sentinel lymph nodesXinYi Lin, Wei Sun, Min Ren, et al.Cancer Management and Research|November 15, 2018
Prognostic significance of pretreatment lymphocyte/monocyte ratio in retroperitoneal liposarcoma patients after radical resectionPeng Luo, Weiluo Cai, Lingge Yang, et al.Journal of Surgical Oncology|August 29, 2023
Optimal timing of re-excision in synovial sarcoma patients: Immediate intervention versus waiting for local recurrenceHongqiang Zhang, Wei Sun, Wending Huang, et al.ACS Biomaterials Science & Engineering|January 18, 2021
Monodisperse Hollow MnO2 with Biodegradability for Efficient Targeted Drug DeliveryMo Cheng, Yan Yu, Wending Huang, et al.Signal Transduction and Targeted Therapy|October 24, 2023
Characteristics of premanufacture CD8+T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphomaYao Wang, Chuan Tong, Yuting Lu, et al.Clinical and Experimental Medicine|June 10, 2023
Survival impact of immediate complete lymph node dissection for Chinese acral and cutaneous melanoma with micrometastasis in sentinel nodes: a retrospective studyJingqin Zhong, Zijian Zou, Tu Hu, et al.Food Chemistry|April 23, 2025
Antimicrobial properties and preservation potential of Allium sativum L-derived extracellular vesicle-like particles for food applicationsChenqi Zhu, Xiaoxiao Ke, Yi Gu, et al.Pharmaceuticals (Basel, Switzerland)|January 21, 2023
Adjuvant Anti-PD-1 Immunotherapy versus Conventional Therapy for Stage III Melanoma: A Real-World Retrospective Cohort StudyTong Li, Yu Xu, Wei Sun, et al.Pageof 11